Oric Pharmaceuticals, Inc. ORIC Enterprise value

Enterprise value at other companies

PfizerPFE

$222.4B+9.2%

ArriVent BioPharma, Inc.AVBP

$958.05M+65.4%

CG OncologyCGON

$6.26B+220%

Olema Pharmaceuticals, Inc.OLMA

$1.25B+502%

Stoke Therapeutics, Inc.STOK

$1.77B+1,855%

NTH

Neonc Technologies HoldingsNTHI

$116.15M+64.4%

FAQ

What is Oric Pharmaceuticals, Inc.'s enterprise value?

Oric Pharmaceuticals, Inc. (ORIC) reported enterprise value of $1.37B in Q1 2026.

How has Oric Pharmaceuticals, Inc.'s enterprise value changed year-over-year?

Oric Pharmaceuticals, Inc.'s enterprise value increased by 290.1% year-over-year, from $350.21M to $1.37B.

What is the long-term trend for Oric Pharmaceuticals, Inc.'s enterprise value?

Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s enterprise value has grown at a 20.0% compound annual growth rate (CAGR), from $366.08M to $758.42M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.